Press releases
* (R) = Regulatory press releases
May 23, 2022
(R) Annual General Meeting in Cantargia AB (publ)
May 17, 2022
Invitation to presentation of Cantargia’s report for the first quarter of 2022 on May 23 at 10.00 a.m. CET
Apr 27, 2022
(R) Cantargia to present new clinical data on lead IL1RAP antibody nadunolimab over three sessions at ASCO 2022
Mar 10, 2022